Eclampsia Clinical Trial
Official title:
Comparison of Loading Dose Magnesium Sulphate With Prichard Regimen in the Management of Severe Preeclampsia and Eclampsia in a Resource Poor Setting, Southeast Nigeria.
Preeclampsia/eclampsia is part of a spectrum of multi-systemic pregnancy disorder that contributes substantially to maternal and perinatal morbidity and mortality, especially in low resource setting. This study was done in Abakaliki, Ebonyi State, Southeast Nigeria. To compare the efficacy of loading dose of magnesium sulphate with that of the Pritchard regimen in the prevention of eclampsia in severe preeclampsia and recurrent fits in eclampsia in a low resource setting. A prospective, single blinded randomized controlled study of loading dose versus Pritchard regimens of MgSO4 at the Teaching Hospital Abakaliki. One hundred and twenty patients were recruited 60 to each arm using computer-generated numbers. Sociodemographic characteristics, efficacy and adverse effects of the drug on the mother and baby were noted.
Background: Preeclampsia/eclampsia is part of a spectrum of multi-systemic pregnancy disorder that contributes substantially to maternal and perinatal morbidity and mortality, especially in low resource setting. This study was done in Abakaliki, Ebonyi State, Southeast Nigeria. Objectives: To compare the efficacy of loading dose of magnesium sulphate with that of the Pritchard regimen in the prevention of eclampsia in patients with severe preeclampsia and recurrent fits in eclampsia in a low resource setting like ours. Methods: This was a prospective, single blinded randomized controlled study of loading dose versus Pritchard regimens of MgSO4 at Alex Ekwueme Federal University Teaching Hospital Abakaliki. One hundred and twenty patients were recruited 60 to each arm using computer-generated numbers. Social demographic characteristics, efficacy and adverse effects of the drug on the mother and baby were noted. Data were collated, tabulated and analyzed using the statistical package for social sciences (SPSS) software (version 22, Chicago II, USA) ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02911701 -
Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features
|
Phase 4 | |
Recruiting |
NCT06377878 -
The Preeclampsia Registry
|
||
Recruiting |
NCT02020174 -
The Preeclampsia Registry
|
||
Completed |
NCT05121415 -
Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy
|
||
Recruiting |
NCT02920593 -
A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy
|
Phase 4 | |
Recruiting |
NCT02578810 -
PIERS and BIS, sFIT:PIGF, Adrenomedullin
|
||
Completed |
NCT05143710 -
The Clinical and Prognostic Features of PRES
|
||
Completed |
NCT03028194 -
Postpartum Uterine Curettage in the Recovery From Preeclampsia/Eclampsia
|
N/A | |
Recruiting |
NCT05678062 -
Point-of-care Ultrasound Abnormalities in Eclampsia
|
N/A | |
Unknown status |
NCT02256995 -
uChek Pilot Study for Urinalysis in the Antenatal Care Setting
|
N/A | |
Completed |
NCT01751945 -
Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project
|
N/A | |
Recruiting |
NCT06069102 -
Optimal Blood Pressure Treatment Thresholds Postpartum
|
Phase 4 | |
Recruiting |
NCT06219109 -
Pulmonary Edema Resolution in Severe Preeclampsia and Eclampsia
|
||
Recruiting |
NCT06281665 -
Treatment With Aspirin After Preeclampsia: TAP Trial
|
Phase 4 | |
Completed |
NCT04160923 -
Incidence and Neonatal Outcome of Eclamptic Parturient in Tertiary Hospital.
|
||
Completed |
NCT02765906 -
Comparing Different Methods of Patient Education on Preeclampsia
|
N/A | |
Recruiting |
NCT01856387 -
The Effect of neutrophil-to Lymphocyte Ratio in Preeclampsia- Eclampsia
|
N/A | |
Recruiting |
NCT03200743 -
Catestatin and Hypertension in Pregnancy
|
N/A | |
Not yet recruiting |
NCT04855513 -
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
|
N/A | |
Completed |
NCT00000534 -
Calcium for Pre-Eclampsia Prevention (CPEP)
|
Phase 3 |